期刊文献+

阿托伐他汀钙非对映异构体(3S,5R)的全合成 被引量:1

Total Synthesis of (3S,5R)- epimers of Atorvastatin Calcium
下载PDF
导出
摘要 目的:合成阿托伐他汀钙非对映异构体。方法:以(R)-6-氰基-3-氧代-己酸叔丁酯为起始原料经羰基还原、O-烃化、氰基还原、与M-4发生Paal-Knorr反应、脱保护、酯水解、成盐等共7步反应合成了阿托伐他汀钙异构体(3S,5R)(1)。其结构经1H-NMR、ESI-MS、HPLC确证。结论:合成得到了目标化合物,可为阿托伐他汀钙的杂质研究提供可靠参数。 Objective: To synthesis (3S, 5R)-epimers of Atorvastatin Calcium. Methods: The (3S, 5R)-epimers of Atorvastatin Calcium was obtained from (R)-tert-butyl 6-cyano- 5-hydroxy -3-oxohexanoate by condensation of carbonyl group, O-alkylation, condensation of cyanogroup, Paal-Knorr reaction with M-4, deprotection, hydrolysis of ester, salinization. The structures were confin-aed by ^1H-NMR, ESI-MS, HPLC. Conclusion: The target compound was synthesized by this method, which provides an important reference for the research on impurities of atorvastatin.
出处 《广东化工》 CAS 2012年第10期29-30,共2页 Guangdong Chemical Industry
关键词 阿托伐他汀钙非对映异构体 合成 杂质 (3S, 5R)-epimers ofatorvastatin calcium synthesis: impurities
  • 相关文献

参考文献4

二级参考文献50

  • 1徐颂.阿托伐他汀钙合成路线[J].中国新药杂志,2006,15(22):1913-1917. 被引量:11
  • 2JAN STACH, JAROSLAV HAVLICEK, LUKAS PLACEK. Syn- thesis of some impurities and degradation products of atorvastatin [J]. Collect Czech Chem Commun, 2008, 73(2) : 229 -246.
  • 3JA 萨提盖利,M 萨勒曼,S 拉瓦特,等.阿托伐他汀的制备方法:中国,1980890A[P].2007-06-13.
  • 4Y 库马,SMD 库马,S 沙希亚纳拉亚纳.无定形形式的阿托伐他汀钙的制备方法:中国,1942439A[P].2007-04-04.
  • 5HAJKOVA M, KRATOCHVIL B, RADL S. Atorvastatin-the world's best selling drug[J]. Chem Listy, 2008, 102(1) :3 -14.
  • 6BROWER PL, BUTLER DE, DEERING CF,et al. The synthesis of (4R-cis) -1, 1 -dimethylethyl, 6-cyanomethyl-2,2-dimethyl-1, 3-dioxane4-acetate, a key intermediate for the preparation of CI- 981, a highly potent, tissue selective inhibitor of HMG-CoA re- ductase [ J ]. Tetrahedron Lett, 1992, 33 (17) : 2279 - 2282.
  • 7BAUMANN KL, BUTLER DE, DEERING CF,et al. The con- vergent synthesis of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase[ J]. Tetrahedron Lett, 1992, 33(17) : 2283 -2284.
  • 8RADL S. A new way to tert-butyl [ (4R,6R)-6-aminoethyl-2,2- dimethyl-1,3-dioxan-4-yl ] acetate, a key intermediate of atorvas- tatin synthesis[J]. Synth Commun, 2003, 33 (13): 2275 - 2283.
  • 9SIDIKA E, ESRA SA, LALE E, et al. An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets [ J ]. J Pharm Biomed Anal, 2003, 33 (5) : 1017 - 1023.
  • 10KADAV AA, VORA DN. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets [ J ]. J Pharm Biomed Anal, 2008, 48(1) :120 -126.

共引文献10

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部